Bone marrow-derived cells implanted into freeze-injured urinary bladders reconstruct functional smooth muscle layers

LUTS: Lower Urinary Tract Symptoms

Volumn 2, Issue 1, 2010, Pages 1-10

  Imamura, Tetsuya ^a   Ishizuka, Osamu ^a   Yamamoto, Tokunori ^b   Gotoh, Momokazu ^b   Nishizawa, Osamu ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bone marrow derived cell; Freeze injured urinary bladder; Microenvironment; Tissue engineering

Indexed keywords

CALPONIN; CXCL1 CHEMOKINE; DESMIN; EPIREGULIN; FIBROBLAST GROWTH FACTOR 5; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; INHIBIN; INTERLEUKIN 11; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MYOSIN HEAVY CHAIN; OSTEOPONTIN; PROCOLLAGEN C PROTEINASE; SCATTER FACTOR; SMOOTH MUSCLE ACTIN; TRANSFORMING GROWTH FACTOR BETA1; TREFOIL PEPTIDE; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; BLADDER CONTRACTION; BLADDER INJURY; BLADDER MUSCLE; BONE MARROW TRANSPLANTATION; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; COLD INJURY; FREEZING; HOST CELL; MOUSE; MULTIPOTENT STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SMOOTH MUSCLE FIBER; TISSUE ENGINEERING; TISSUE REGENERATION; UPREGULATION;

EID: 79953718479     PISSN: 17575664     EISSN: 17575672     Source Type: Journal    
DOI: 10.1111/j.1757-5672.2010.00066.x     Document Type: Review

References (95)

1. Waksman R, Baffour R. Bone marrow and bone marrow derived mononuclear stem cells therapy for the chronically ischemic myocardium. Cardiovasc Radiat Med 2003; 4: 164-8.
2. Wang XJ, Li QP. The roles of mesenchymal stem cells (MSCs) therapy in ischemic heart diseases. Biochem Biophys Res Commun 2007; 359: 189-93.
3. Anumanthan G, Makari JH, Honea L et al. Directed differentiation of bone marrow derived mesenchymal stem cells into bladder urothelium. J Urol 2008; 180: 1778-83.
4. Furuta A, Jankowski RJ, Honda M, Pruchnic R, Yoshimura N, Chancellor MB. State of the art of where we are at using stem cells for stress urinary incontinence. Neurourol Urodyn 2007; 26: 966-71.
5. Hwang JH, Yuk SH, Lee JH et al. Isolation of muscle derived stem cells from rat and its smooth muscle differentiation [corrected]. Mol Cells 2004; 17: 57-61.
6. Jack GS, Almeida FG, Zhang R, Alfonso ZC, Zuk PA, Rodriguez LV. Processed lipoaspirate cells for tissue engineering of the lower urinary tract: implications for the treatment of stress urinary incontinence and bladder reconstruction. J Urol 2005; 174: 2041-5.
7. Lai JY, Yoon CY, Yoo JJ, Wulf T, Atala A. Phenotypic and functional characterization of in vivo tissue engineered smooth muscle from normal and pathological bladders. J Urol 2002; 168: 1853-7; discussion 58.
8. Lin CS, Xin ZC, Deng CH, Ning H, Lin G, Lue TF. Recent advances in andrology-related stem cell research. Asian J Androl 2008; 10: 171-5.
9. Ning H, Liu G, Lin G. et al Identification of an aberrant cell line among human adipose tissue-derived stem cell isolates. Differentiation 2009; 77: 172-80.
10. Oberpenning F, Meng J, Yoo JJ, Atala A. De novo reconstitution of a functional mammalian urinary bladder by tissue engineering. Nat Biotechnol 1999; 17: 149-55.
11. Pariente JL, Kim BS, Atala A. In vitro biocompatibility assessment of naturally derived and synthetic biomaterials using normal human urothelial cells. J Biomed Mater Res 2001; 55: 33-9.
12. Shukla D, Box GN, Edwards RA, Tyson DR. Bone marrow stem cells for urologic tissue engineering. World J Urol 2008; 26: 341-9.
13. Smaldone MC, Chancellor MB. Muscle derived stem cell therapy for stress urinary incontinence. World J Urol 2008; 26: 327-32.
14. Smaldone MC, Chen ML, Chancellor MB. Stem cell therapy for urethral sphincter regeneration. Minerva Urol Nefrol 2009; 61: 27-40.
15. Berjukow S, Margreiter E, Marksteiner R, Strasser H, Bartsch G, Hering S. Membrane properties of single muscle cells of the rhabdosphincter of the male urethra. Prostate 2004; 58: 238-47.
16. Cannon TW, Lee JY, Somogyi G et al. Improved sphincter contractility after allogenic muscle-derived progenitor cell injection into the denervated rat urethra. Urology 2003; 62: 958-63.
17. Yiou R, Dreyfus P, Chopin DK, Abbou CC, Lefaucheur JP. Muscle precursor cell autografting in a murine model of urethral sphincter injury. BJU Int 2002; 89: 298-302.
18. Yiou R, Lefaucheur JP, Atala A. The regeneration process of the striated urethral sphincter involves activation of intrinsic satellite cells. Anat Embryol (Berl) 2003; 206: 429-35.
19. Yokoyama T, Pruchnic R, Lee JY et al. Autologous primary muscle-derived cells transfer into the lower urinary tract. Tissue Eng 2001; 7: 395-404.
20. Imamura T, Kinebuchi Y, Ishizuka O, Seki S, Igawa Y, Nishizawa O. Implanted mouse bone marrow-derived cells reconstruct layered smooth muscle structures in injured urinary bladders. Cell Transplant 2008; 17: 267-78.
21. Jiang Y, Vaessen B, Lenvik T, Blackstad M, Reyes M, Verfaillie CM. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol 2002; 30: 896-904.
22. Peister A, Mellad JA, Larson BL, Hall BM, Gibson LF, Prockop DJ. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 2004; 103: 1662-8.
23. Hegner B, Weber M, Dragun D, Schulze-Lohoff E. Differential regulation of smooth muscle markers in human bone marrow-derived mesenchymal stem cells. J Hypertens 2005; 23: 1191-202.
24. Kanematsu A, Yamamoto S, Iwai-Kanai E et al. Induction of smooth muscle cell-like phenotype in marrow-derived cells among regenerating urinary bladder smooth muscle cells. Am J Pathol 2005; 166: 565-73.
25. Wang T, Xu Z, Jiang W, Ma A. Cell-to-cell contact induces mesenchymal stem cell to differentiate into cardiomyocyte and smooth muscle cell. Int J Cardiol 2006; 109: 74-81.
26. Cho SW, Kim IK, Lim SH. et al Smooth muscle-like tissues engineered with bone marrow stromal cells. Biomaterials 2004; 25: 2979-86.
27. Cho SW, Park HJ, Ryu JH. et al Vascular patches tissue-engineered with autologous bone marrow-derived cells and decellularized tissue matrices. Biomaterials 2005; 26: 1915-24.
28. Chung SY, Krivorov NP, Rausei V et al. Bladder reconstitution with bone marrow derived stem cells seeded on small intestinal submucosa improves morphological and molecular composition. J Urol 2005; 174: 353-9.
29. Zhang Y, Lin HK, Frimberger D, Epstein RB, Kropp BP. Growth of bone marrow stromal cells on small intestinal submucosa: an alternative cell source for tissue engineered bladder. BJU Int 2005; 96: 1120-5.
30. Abdallah BM, Kassem M. Human mesenchymal stem cells: from basic biology to clinical applications. Gene Ther 2008; 15: 109-16.
31. Devine SM. Mesenchymal stem cells: will they have a role in the clinic? J Cell Biochem Suppl 2002; 38: 73-9.
32. Haider H, Ashraf M. Bone marrow cell transplantation in clinical perspective. J Mol Cell Cardiol 2005; 38: 225-35.
33. Kassem M, Abdallah BM. Human bone-marrow-derived mesenchymal stem cells: biological characteristics and potential role in therapy of degenerative diseases. Cell Tissue Res 2008; 331: 157-63.
34. Badylak SF, Kochupura PV, Cohen IS et al. The use of extracellular matrix as an inductive scaffold for the partial replacement of functional myocardium. Cell Transplant 2006; 15(Suppl 1): S29-40.
35. Dahl SL, Koh J, Prabhakar V, Niklason LE. Decellularized native and engineered arterial scaffolds for transplantation. Cell Transplant 2003; 12: 659-66.
36. Guan J, Stankus JJ, Wagner WR. Development of composite porous scaffolds based on collagen and biodegradable poly(ester urethane)urea. Cell Transplant 2006; 15(Suppl 1): S17-27.
37. Owens GK, Wise G. Regulation of differentiation/maturation in vascular smooth muscle cells by hormones and growth factors. Agents Actions Suppl 1997; 48: 3-24.
38. Bian J, Kiedrowski M, Mal N, Forudi F, Penn MS. Engineered cell therapy for sustained local myocardial delivery of nonsecreted proteins. Cell Transplant 2006; 15: 67-74.
39. Patel AN, Spadaccio C, Kuzman M et al. Improved cell survival in infarcted myocardium using a novel combination transmyocardial laser and cell delivery system. Cell Transplant 2007; 16: 899-905.
40. Coyne TM, Marcus AJ, Woodbury D, Black IB. Marrow stromal cells transplanted to the adult brain are rejected by an inflammatory response and transfer donor labels to host neurons and glia. Stem Cells 2006; 24: 2483-92.
41. Dai W, Field LJ, Rubart M. et al Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts. J Mol Cell Cardiol 2007; 43: 504-16.
42. Djouad F, Delorme B, Maurice M et al. Microenvironmental changes during differentiation of mesenchymal stem cells towards chondrocytes. Arthritis Res Ther 2007; 9: R33.
43. Srivastava AS, Shenouda S, Mishra R, Carrier E. Transplanted embryonic stem cells successfully survive, proliferate, and migrate to damaged regions of the mouse brain. Stem Cells 2006; 24: 1689-94.
44. Imamura T, Yamamoto T, Ishizuka O, Gotoh M, Nishizawa O. The microenvironment of freeze-injured mouse urinary bladders enables successful tissue engineering. Tissue Eng Part A 2009; 15: 3367-75.
45. Somogyi GT, Yokoyama T, Szell EA et al. Effect of cryoinjury on the contractile parameters of bladder strips: a model of impaired detrusor contractility. Brain Res Bull 2002; 59: 23-8.
46. Long X, Olszewski M, Huang W, Kletzel M. Neural cell differentiation in vitro from adult human bone marrow mesenchymal stem cells. Stem Cells Dev 2005; 14: 65-9.
47. Madeddu P, Emanueli C, Pelosi E et al. Transplantation of low dose CD34+KDR+ cells promotes vascular and muscular regeneration in ischemic limbs. FASEB J 2004; 18: 1737-9.
48. Phinney DG, Isakova I. Plasticity and therapeutic potential of mesenchymal stem cells in the nervous system. Curr Pharm Des 2005; 11: 1255-65.
49. Takahashi T, Kalka C, Masuda H et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999; 5: 434-8.
50. Ge Z, Goh JC, Lee EH. Selection of cell source for ligament tissue engineering. Cell Transplant 2005; 14: 573-83.
51. Yamamoto T, Tada T, Brodsky SV et al. Intravital videomi-croscopy of peritubular capillaries in renal ischemia. Am J Physiol Renal Physiol 2002; 282: F1150-55.
52. Frid MG, Shekhonin BV, Koteliansky VE, Glukhova MA. Phenotypic changes of human smooth muscle cells during development: late expression of heavy caldesmon and calponin. Dev Biol 1992; 153: 185-93.
53. Hautmann MB, Adam PJ, Owens GK. Similarities and differences in smooth muscle alpha-actin induction by TGF-beta in smooth muscle versus non-smooth muscle cells. Arterioscler Thromb Vasc Biol 1999; 19: 2049-58.
54. Hungerford JE, Owens GK, Argraves WS, Little CD. Development of the aortic vessel wall as defined by vascular smooth muscle and extracellular matrix markers. Dev Biol 1996; 178: 375-92.
55. Li L, Liu Z, Mercer B, Overbeek P, Olson EN. Evidence for serum response factor-mediated regulatory networks governing SM22alpha transcription in smooth, skeletal, and cardiac muscle cells. Dev Biol 1997; 187: 311-21.
56. Miano JM, Cserjesi P, Ligon KL, Periasamy M, Olson EN. Smooth muscle myosin heavy chain exclusively marks the smooth muscle lineage during mouse embryogenesis. Circ Res 1994; 75: 803-12.
57. Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 1995; 75: 487-517.
58. Ya J, Markman MW, Wagenaar GT, Blommaart PJ, Moorman AF, Lamers WH. Expression of the smooth-muscle proteins alpha-smooth-muscle actin and calponin, and of the intermediate filament protein desmin are parameters of cardiomyocyte maturation in the prenatal rat heart. Anat Rec 1997; 249: 495-505.
59. Hughes S, Chan-Ling T. Characterization of smooth muscle cell and pericyte differentiation in the rat retina in vivo. Invest Ophthalmol Vis Sci 2004; 45: 2795-806.
60. Mitchell JJ, Reynolds SE, Leslie KO, Low RB, Woodcock-Mitchell J. Smooth muscle cell markers in developing rat lung. Am J Respir Cell Mol Biol 1990; 3: 515-23.
61. Fang B, Shi M, Liao L, Yang S, Liu Y, Zhao RC. Systemic infusion of FLK1(+) mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice. Transplantation 2004; 78: 83-8.
62. Kudo M, Wang Y, Wani MA, Xu M, Ayub A, Ashraf M. Implantation of bone marrow stem cells reduces the infarction and fibrosis in ischemic mouse heart. J Mol Cell Cardiol 2003; 35: 1113-9.
63. Ricardo SD, Deane JA. Adult stem cells in renal injury and repair. Nephrology (Carlton) 2005; 10: 276-82.
64. Becker C, Laeufer T, Arikkat J, Jakse G. TGFbeta-1 and epithelial-mesenchymal interactions promote smooth muscle gene expression in bone marrow stromal cells: possible application in therapies for urological defects. Int J Artif Organs 2008; 31: 951-9.
65. Kinner B, Zaleskas JM, Spector M. Regulation of smooth muscle actin expression and contraction in adult human mesenchymal stem cells. Exp Cell Res 2002; 278: 72-83.
66. Wang D, Park JS, Chu JS. et al Proteomic profiling of bone marrow mesenchymal stem cells upon transforming growth factor beta1 stimulation. J Biol Chem 2004; 279: 43725-34.
67. Lenga Y, Koh A, Perera AS, McCulloch CA, Sodek J, Zohar R. Osteopontin expression is required for myofibroblast differentiation. Circ Res 2008; 102: 319-27.
68. Pereira RO, Carvalho SN, Stumbo AC et al. Osteopontin expression in coculture of differentiating rat fetal skeletal fibroblasts and myoblasts. In Vitro Cell Dev Biol Anim 2006; 42: 4-7.
69. Agrotis A, Samuel M, Prapas G, Bobik A. Vascular smooth muscle cells express multiple type I receptors for TGF-beta, activin, and bone morphogenetic proteins. Biochem Biophys Res Commun 1996; 219: 613-8.
70. Cho SH, Yao Z, Wang SW et al. Regulation of activin A expression in mast cells and asthma: its effect on the proliferation of human airway smooth muscle cells. J Immunol 2003; 170: 4045-52.
71. Ishisaki A, Hayashi H, Li AJ, Imamura T. Human umbilical vein endothelium-derived cells retain potential to differentiate into smooth muscle-like cells. J Biol Chem 2003; 278: 1303-9.
72. Kojima I, Mogami H, Kawamura N, Yasuda H, Shibata H. Modulation of growth of vascular smooth muscle cells by activin A. Exp Cell Res 1993; 206: 152-6.
73. Riedy MC, Brown MC, Molloy CJ, Turner CE. Activin A and TGF-beta stimulate phosphorylation of focal adhesion proteins and cytoskeletal reorganization in rat aortic smooth muscle cells. Exp Cell Res 1999; 251: 194-202.
74. You L, Kruse FE. Differential effect of activin A and BMP-7 on myofibroblast differentiation and the role of the Smad signaling pathway. Invest Ophthalmol Vis Sci 2002; 43: 72-81.
75. Sparrow MP, Lamb JP. Ontogeny of airway smooth muscle: structure, innervation, myogenesis and function in the fetal lung. Respir Physiol Neurobiol 2003; 137: 361-72.
76. Suarez-Rodriguez R, Belkind-Gerson J. Cultured nestin-positive cells from postnatal mouse small bowel differentiate ex vivo into neurons, glia, and smooth muscle. Stem Cells 2004; 22: 1373-85.
77. Tollet J, Everett AW, Sparrow MP. Development of neural tissue and airway smooth muscle in fetal mouse lung explants: a role for glial-derived neurotrophic factor in lung innervation. Am J Respir Cell Mol Biol 2002; 26: 420-9.
78. Li M, Carpio DF, Zheng Y et al. An essential role of the NF-kappa B/toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J Immunol 2001; 166: 7128-35.
79. Yamada H, Takahashi S, Fujita H, Kobayashi N, Okabe S. Cytokine-induced neutrophil chemoattractants in healing of gastric ulcers in rats: expression of >40-kDa chemoattractant in delayed ulcer healing by indomethacin. Dig Dis Sci 1999; 44: 889-95.
80. Gerecht-Nir S, Dazard JE, Golan-Mashiach M et al. Vascular gene expression and phenotypic correlation during differentiation of human embryonic stem cells. Dev Dyn 2005; 232: 487-97.
81. Brogi E, Winkles JA, Underwood R, Clinton SK, Alberts GF, Libby P. Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. Association of acidic FGF with plaque microvessels and macrophages. J Clin Invest 1993; 92: 2408-18.
82. Oertel M, Graness A, Thim L, Buhling F, Kalbacher H, Hoffmann W. Trefoil factor family-peptides promote migration of human bronchial epithelial cells: synergistic effect with epidermal growth factor. Am J Respir Cell Mol Biol 2001; 25: 418-24.
83. Playford RJ. Trefoil peptides: what are they and what do they do? J R Coll Physicians Lond 1997; 31: 37-41.
84. He JQ, Shumansky K, Connett JE, Anthonisen NR, Pare PD, Sandford AJ. Association of genetic variations in the CSF2 and CSF3 genes with lung function in smoking-induced COPD. Eur Respir J 2008; 32: 25-34.
85. Bratincsak A, Lonyai A, Shahar T, Hansen A, Toth ZE, Mezey E. Using brain slice cultures of mouse brain to assess the effect of growth factors on differentiation of bone marrow derived stem cells. Ideggyogy Sz 2007; 60: 124-9.
86. Nishida T, Tsuji S, Tsujii M et al. Cultured bone marrow cell local implantation accelerates healing of ulcers in mice. J Gastroenterol 2008; 43: 124-35.
87. Ohnishi S, Yasuda T, Kitamura S, Nagaya N. Effect of hypoxia on gene expression of bone marrow-derived mesenchymal stem cells and mononuclear cells. Stem Cells 2007; 25: 1166-77.
88. Jerareungrattan A, Sila-asna M, Bunyaratvej A. Increased smooth muscle actin expression from bone marrow stromal cells under retinoic acid treatment: an attempt for autologous blood vessel tissue engineering. Asian Pac J Allergy Immunol 2005; 23: 107-13.
89. Tamama K, Sen CK, Wells A. Differentiation of bone marrow mesenchymal stem cells into the smooth muscle lineage by blocking ERK/MAPK signaling pathway. Stem Cells Dev 2008; 17: 897-908.
90. Panetta NJ, Gupta DM, Longaker MT. Bone regeneration and repair. Curr Stem Cell Res Ther 2009. [Accessed 18 March 2010] Available from URL: http://www.ncbi.nlm.nih.gov/pubmed/19941457?dopt=Citation.
91. Williams CA, Lavik EB. Engineering the CNS stem cell microenvironment. Regen Med 2009; 4: 865-77.
92. Zhang H, Wang W, Quan C, Fan S. Engineering considerations for process development in mammalian cell cultivation. Curr Pharm Biotechnol 2009; 11: 103-112.
93. Zippel N, Schulze M, Tobiasch E. Biomaterials and mesenchymal stem cells for regenerative medicine. Recent Pat Biotechnol 2009; [Epub ahead of print].
94. Imamura T, Cui L, Teng R et al. Embryonic stem cell-derived embryoid bodies in three-dimensional culture system form hepatocyte-like cells in vitro and in vivo. Tissue Eng 2004; 10: 1716-24.
95. Imamura T, Kinebuchi Y, Ishizuka O, Seki S, Igawa Y, Nishizawa O. Three-dimensional culture systems for differentiation of mice embryonic stem cells into hepatocyte-like cells. J Org Dysfunct 2007; 4: 57-64.